Friday 23 Mar 2018
Membership in the NASSHP is open to all clinicians and scientists who have an interest in the study of hypertensive complications of pregnancy and its related fields.
Read more ...
NASSHP's 2015 Scientific Meeting is on October 16, 2015 in Chicago, Illinois.
Read more ...
President's Page
News and information about NASSHP, directly from the Society's 2014-2016 President, Eugene Chang, MD.
Read more ...


  • Increase font size
  • Default font size
  • Decrease font size

About Us

Written by Super User. Posted in About Us

Contact Us:

North American Society for the Study of Hypertension in Pregnancy (NASSHP)
c/o Sara Gauthier
6905 N. Wickham Road, Suite 302
Melbourne, FL 32940
(Tel) 321-421-6699
(Fax) 321-821-0450


President 2014-2016

Eugene Chang, MD
Division of Maternal Fetal Medicine, Medical University of South Carolina, Charleston, SC, USA

Dr. "Gene" Chang is Director of Maternal Fetal Fellowship and Associate Professor at Medical University of South Carolina. Board-certified in Maternal-Fetal Medicine, his practice includes a Prenatal Wellness Center, and he specializes in hypertensive disorders of pregnancy, intrauterine growth restriction, and preterm birth. Dr. Chang graduated from Medical College of Virginia, and then served his internship at MUSC. After completing active service in the US Air Force, Dr. Chang continued at MUSC with his residency and fellowship. 

President Elect

Arun Jeyabalan, MD
Magee Womens Research Institute, University of Pittsburgh, Pittsburgh, PA, USA

Dr. Arun Jeyabalan graduated from University of Michigan Medical School, serving her residency at University of California at San Diego Medical Center, and then completed fellowships at Magee Womens Hospital. She is board-certified in both Obstetrics & Gynecology as well as Maternal-Fetal Medicine.



Sarosh Rana, MD, MPH
Section Chief, Maternal Fetal Medicine, Associate Professor of Obstetrics and Gynecology
University of Chicago, Chicago, IL

Dr. Sarosh Rana specializes in maternal-fetal medicine, with major clinical interest in managing high-risk pregnancies, especially those complicated by high blood pressure and preeclampsia, as well as those with fetal growth restriction. Her main research, funded by the NIH, focuses on evaluating novel biomarkers as a tool for prediction of adverse outcomes among women with preeclampsia. The long-term goal of this research is to select women with early preeclampsia who can be managed conservatively to gain more time for the baby, and possibly avoid early deliveries.

Board Members:

Anne-Marie Côte, M.D. Universite de Sherbrooke, Canada

Hilary Gammill, University of Washington, USA

Donna Johnson, M.D. Medical University of South Carolina, USA

Michelle Owens, M.D. University of Mississippi, USA


NASSHP Past Presidents:

Douglas A. Woelkers, MD
University of California, 2012-2014

Robert W. Powers, PhD
University of Pittsburgh, 2010-2012

Denise Raynor, MD
Emory University, 2008-2010

Peter von Dadelszen, MBChB, DPhil,
University of British Columbia, 2006-2008

Thomas Easterling, MD,
University of Washington, 2003-2006

John Repke, MD,
Penn State University, 2000-2003

James Martin, MD,
University of Mississippi, 1997-2000

James Roberts, MD,
University of Pittsburgh 1994-1997